Evaluation of Efficacy and Safety of SPARC1401 in Acute Low Back Pain

NCT02887534 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Acute Muscle Pain

Interventions

DRUG: SPARC1401-low dose
DRUG: SPARC1401-mid dose
DRUG: SPARC1401-high dose
DRUG: Reference1401 (Tizanidine)
DRUG: Placebo1401

Sponsor

Sun Pharma Advanced Research Company Limited